Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy

PURPOSE: For esophageal cancer patients with a clinical complete response (cCR) after standard-dose radiotherapy with concurrent chemotherapy, data on the survival outcomes and recurrence patterns remain scarce. To evaluate the impact of dose escalation on overall survival for this subset of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Luo, Yijun, Wang, Xiaoli, Han, Gaohua, Wang, Peng, Yuan, Wei, Dai, Sheng-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097517/
https://www.ncbi.nlm.nih.gov/pubmed/30147366
http://dx.doi.org/10.2147/CMAR.S160909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097517/
https://www.ncbi.nlm.nih.gov/pubmed/30147366
http://dx.doi.org/10.2147/CMAR.S160909

Ejemplares similares